NCM Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

NCM Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$355K	Hold	1,865	–	–	0.11%	150
2026 Q1	$315K	Hold	1,865	–	–	0.11%	149
2025 Q4	$315K	Hold	1,865	–	–	0.12%	147
2025 Q3	$269K	Hold	1,865	–	–	0.1%	152
2025 Q2	$236K	Hold	1,865	–	–	0.1%	162
2025 Q1	$239K	Hold	1,865	–	–	0.11%	156
2024 Q4	$247K	Hold	1,865	–	–	0.11%	154
2024 Q3	$272K	Hold	1,865	–	–	0.13%	141
2024 Q2	$256K	Hold	1,865	–	–	0.13%	138
2024 Q1	$256K	Hold	1,865	–	–	0.14%	136
2023 Q4	$253K	Sell	1,865 -170	-8%	-$20.7K	0.15%	135
2023 Q3	$249K	Hold	2,035	–	–	0.18%	127
2023 Q2	$258K	Buy	2,035 +20	+1%	+$2.6K	0.18%	127
2023 Q1	$260K	Hold	2,015	–	–	0.19%	124
2022 Q4	$265K	Hold	2,015	–	–	0.17%	141
2022 Q3	$236K	Hold	2,015	–	–	0.18%	147
2022 Q2	$237K	Hold	2,015	–	–	0.17%	151
2022 Q1	$263K	Hold	2,015	–	–	0.17%	157
2021 Q4	$308K	Buy	+2,015	New	+$312K	0.27%	109

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

NCM Capital Management's IBB Position: Q2 2026 in Review

NCM Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,865 shares worth $355K. The position accounts for 0.11% of the portfolio, ranked #150.

NCM Capital Management first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

NCM Capital Management held 1,865 shares of iShares Biotechnology ETF worth $355K as of Q2 2026.
NCM Capital Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.11% of NCM Capital Management's portfolio in Q2 2026, its #150 holding.
NCM Capital Management first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on NCM Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.